You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 11, 2025

Drugs Containing Excipient (Inactive Ingredient) CARBOMER HOMOPOLYMER


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing CARBOMER HOMOPOLYMER excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
Axsome Therapeutics Inc AUVELITY dextromethorphan hydrobromide, bupropion hydrochloride 81968-045 CARBOMER HOMOPOLYMER TYPE 2034-11-05
Viatris Specialty LLC LYRICA CR pregabalin 58151-245 CARBOMER HOMOPOLYMER TYPE
Astellas Pharma US Inc VESICARE solifenacin succinate 51248-250 CARBOMER HOMOPOLYMER TYPE
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 3 of 3 entries

CARBOMER HOMOPOLYMER Market Analysis and Financial Projection

Market Dynamics and Financial Trajectory for Carbomer Homopolymer

Introduction to Carbomer Homopolymer

Carbomer homopolymer, a type of polyacrylic acid, is a crucial excipient in the pharmaceutical and personal care industries. It is widely used as a thickening agent, emulsifier, and stabilizer in various formulations. Here, we delve into the market dynamics and financial trajectory of carbomer homopolymer.

Market Size and Growth

The global carbomer homopolymer market is experiencing steady growth. As of 2023, the market was valued at US$ 82 million and is projected to reach US$ 108.8 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period from 2024 to 2030[1].

In the broader context of the carbomer market, which includes both homopolymers and copolymers, the global market size is expected to be significantly larger. For instance, the global carbomer market was valued at USD 866.6 million in 2023 and is anticipated to grow to USD 1657.6 million by 2033, with a CAGR of 6.7% during the forecast period[2].

Key Market Drivers

Increasing Demand in Personal Care

The personal care industry is a significant driver for the carbomer homopolymer market. Carbomers are essential in the formulation of various personal care products such as lotions, creams, shampoos, and sun care items. The rising consumer preference for personal care and cosmetic products is propelling the demand for carbomers, which act as gelling agents or emulsifiers in these products[2].

Pharmaceutical Applications

In the pharmaceutical sector, carbomer homopolymers are used as rheology modifiers, suspension stabilizers, tablet binders, mucoadhesive aids, and bioavailability enhancers. The increasing research and development activities in the pharmaceutical industry to introduce advanced products are surging the demand for pharmaceutical excipients, including carbomers[4].

Regional Demand

The Asia-Pacific region dominates the carbomer market, accounting for a significant share due to the large consumer base in countries like India, China, and Japan. This region's strong consumption potential and growing demand for personal care products indirectly boost the shipments of carbomer homopolymers[5].

Market Segmentation

By Type

The carbomer homopolymer market is segmented by type, with common types including Carbomer 71, Carbomer 971, and Carbomer 981. Each type has specific applications and properties that cater to different needs in the pharmaceutical and personal care industries[1].

By Application

The market is also segmented by application, with the primary segments being personal care & cosmetics and the pharmaceutical industry. Personal care products account for a significant share, driven by the increasing demand for cosmetic and skincare products[1].

By Region

The market is analyzed regionally, with key regions including North America, Western Europe, and the Asia-Pacific. The Asia-Pacific region holds the largest market share due to its vast consumer base and growing demand for personal care and pharmaceutical products[2].

Competitive Landscape

The carbomer homopolymer market is competitive, with several key players dominating the landscape. These include Lubrizol, Tinci Materials, SNF Floerger, Newman Fine Chemical, Evonik, Sumitomo Seika, Corel, DX Chemical, and Maruti Chemicals. These companies are involved in strategic collaborations, partnerships, and capacity expansions to meet the growing demand for high-performance carbomers[1].

Recent Developments

  • Capacity Expansion: Lubrizol Corporation, a major carbomer producer, announced the expansion of its Carbopol® Aqua SF polymer production capacity in North America to meet the growing demand for high-performance carbomers in personal care and pharmaceutical applications[2].
  • Regulatory Approvals: The Korean Ministry of Food and Drug Safety approved BASF’s Luviskol® K30 for use in oral dispersible tablets (ODTs), opening up new opportunities for carbomers in the pharmaceutical market[2].

Challenges and Restraints

Government Regulations

Government regulations, particularly those related to the use of benzene polymerized carbomer, pose a significant challenge. The FDA has identified benzene as a carcinogen, leading to recalls of several hand sanitizers and aerosol medication products. This has prompted manufacturers to switch to alternative methods, increasing manufacturing costs and potentially hampering market growth[4].

COVID-19 Impact

The COVID-19 pandemic had a marginal impact on the carbomer market, particularly during the second and third quarters of 2020. Manufacturing units and supply chains suffered declines due to rising infection rates and government-imposed shutdowns. However, the market has shown signs of recovery since 2021, with increasing demand from personal care and pharmaceutical sectors[5].

Financial Trajectory

The financial trajectory of the carbomer homopolymer market is positive, driven by steady growth in demand from key sectors. Here are some key financial metrics:

  • Market Size (2023): US$ 82 million[1].
  • Forecasted Market Size (2030): US$ 108.8 million[1].
  • CAGR (2024-2030): 4.0%[1].

In the broader carbomer market, the financial outlook is more robust:

  • Market Size (2023): USD 866.6 million[2].
  • Forecasted Market Size (2033): USD 1657.6 million[2].
  • CAGR (2024-2033): 6.7%[2].

Key Takeaways

  • The carbomer homopolymer market is expected to grow at a CAGR of 4.0% from 2024 to 2030.
  • The personal care and pharmaceutical industries are the primary drivers of this market.
  • The Asia-Pacific region dominates the market due to its large consumer base.
  • Key players are expanding their production capacities and seeking regulatory approvals to meet growing demand.
  • Government regulations and the COVID-19 pandemic pose challenges but have not significantly hindered long-term growth.

FAQs

What is the expected growth rate of the carbomer homopolymer market from 2024 to 2030?

The carbomer homopolymer market is expected to grow at a CAGR of 4.0% from 2024 to 2030[1].

Which region dominates the carbomer homopolymer market?

The Asia-Pacific region dominates the carbomer homopolymer market due to its large consumer base and growing demand for personal care and pharmaceutical products[5].

What are the primary applications of carbomer homopolymer?

The primary applications of carbomer homopolymer are in the personal care & cosmetics and pharmaceutical industries[1].

Who are the key players in the carbomer homopolymer market?

Key players include Lubrizol, Tinci Materials, SNF Floerger, Newman Fine Chemical, Evonik, Sumitomo Seika, Corel, DX Chemical, and Maruti Chemicals[1].

How did the COVID-19 pandemic impact the carbomer homopolymer market?

The COVID-19 pandemic had a marginal impact, with declines in manufacturing and supply chains during 2020, but the market has shown signs of recovery since 2021[5].

Sources

  1. Global Carbomer Homopolymer Market Research Report 2024 - Valuates Reports
  2. Carbomer Market Size, Share, Trends | CAGR of 6.7% - Market.US
  3. Excipients Market Size, Share & Trends Analysis Report 2030 - Grand View Research
  4. Carbomer Market Size, Share, Growth | Global Forecast [2032] - Fortune Business Insights
  5. Carbomer Market Trends Analysis & Share Forecast till 2031 - Fact.MR

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.